KB407 In-human Trial Expected After Gene Therapy Found Safe in Animals

KB407 In-human Trial Expected After Gene Therapy Found Safe in Animals

292354

KB407 In-human Trial Expected After Gene Therapy Found Safe in Animals

Krystal Biotech is expecting to start a Phase 1 clinical trial by early fall to test KB407 for cystic fibrosis (CF), after the investigational inhaled gene therapy was found safe and well-tolerated in nonhuman primates. According to Krystal, the positive results from a completed toxicology study will support a required investigational new drug application with the U.S. Food and Drug Administration (FDA). A go-ahead from the FDA will allow Krystal to conduct a first clinical trial…

You must be logged in to read/download the full post.